J&J Accepts $4B Carlyle Offer for Diagnostics Unit

Mon, 03/31/2014 - 8:04am

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson says it has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.

J&J says the deal for the blood-testing unit should close by mid-year. Its shares rose in premarket trading.

The New Brunswick, N.J., health care giant said in January that Washington, D.C.-based Carlyle Group had offered $4.15 billion for the business, and that it would talk to works councils and trade unions representing its employees before making a decision.

The Ortho-Clinical business serves hospitals, testing laboratories and blood banks. It supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases.

It also makes technology for advanced testing of blood to diagnose health conditions and to monitor medication effects.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.